• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

四川省 2019 年冠状病毒病(COVID-19)住院患者的临床特征。

Clinical characteristics of inpatients with coronavirus disease 2019 (COVID-19) in Sichuan province.

机构信息

Chinese Evidence-based Medicine Center and Cochrane China Center, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.

Department of Clinical Research Management, West China Hospital, Sichuan University, Chengdu, 610041, China.

出版信息

BMC Infect Dis. 2021 Feb 8;21(1):155. doi: 10.1186/s12879-021-05825-1.

DOI:10.1186/s12879-021-05825-1
PMID:33557777
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7868861/
Abstract

BACKGROUND

The outbreak of COVID-19 has resulted in serious concerns in China and abroad. To investigate clinical features of confirmed and suspected patients with COVID-19 in west China, and to examine differences between severe versus non-severe patients.

METHODS

Patients admitted for COVID-19 between January 21 and February 11 from fifteen hospitals in Sichuan Province, China were included. Experienced clinicians trained with methods abstracted data from medical records using pre-defined, pilot-tested forms. Clinical characteristics between severe and non-severe patients were compared.

RESULTS

Of the 169 patients included, 147 were laboratory-confirmed, 22 were suspected. For confirmed cases, the most common symptoms from onset to admission were cough (70·7%), fever (70·5%) and sputum (33·3%), and the most common chest CT patterns were patchy or stripes shadowing (78·0%); throughout the course of disease, 19·0% had no fever, and 12·4% had no radiologic abnormality; twelve (8·2%) received mechanical ventilation, four (2·7%) were transferred to ICU, and no death occurred. Compared to non-severe cases, severe ones were more likely to have underlying comorbidities (62·5% vs 26·2%, P = 0·001), to present with cough (92·0% vs 66·4%, P = 0·02), sputum (60·0% vs 27·9%, P = 0·004) and shortness of breath (40·0% vs 8·2%, P <  0·0001), and to have more frequent lymphopenia (79·2% vs 43·7%, P = 0·003) and eosinopenia (84·2% vs 57·0%, P = 0·046).

CONCLUSIONS

The symptoms of patients in west China were relatively mild, and an appreciable proportion of infected cases had no fever, warranting special attention.

摘要

背景

COVID-19 的爆发引起了国内外的严重关注。为了调查中国西部确诊和疑似 COVID-19 患者的临床特征,并研究重症与非重症患者之间的差异。

方法

纳入 2020 年 1 月 21 日至 2 月 11 日期间四川省 15 家医院收治的 COVID-19 患者。经验丰富的临床医生使用预定义的、经过试点测试的表格,根据培训方法从病历中提取数据。比较重症与非重症患者的临床特征。

结果

169 例患者中,147 例为实验室确诊,22 例为疑似。确诊病例从发病到入院最常见的症状为咳嗽(70.7%)、发热(70.5%)和咳痰(33.3%),最常见的胸部 CT 表现为斑片状或条纹状阴影(78.0%);整个病程中,19.0%的患者无发热,12.4%的患者无影像学异常;12 例(8.2%)接受机械通气,4 例(2.7%)转至 ICU,无死亡病例。与非重症病例相比,重症病例更有可能合并基础疾病(62.5% vs. 26.2%,P=0.001),更有可能出现咳嗽(92.0% vs. 66.4%,P=0.02)、咳痰(60.0% vs. 27.9%,P=0.004)和呼吸急促(40.0% vs. 8.2%,P<0.0001),且更常见淋巴细胞减少(79.2% vs. 43.7%,P=0.003)和嗜酸性粒细胞减少(84.2% vs. 57.0%,P=0.046)。

结论

中国西部患者的症状相对较轻,相当一部分感染病例无发热,需要特别注意。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61ec/7869486/d3c7f005e5c2/12879_2021_5825_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61ec/7869486/d3c7f005e5c2/12879_2021_5825_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61ec/7869486/d3c7f005e5c2/12879_2021_5825_Fig1_HTML.jpg

相似文献

1
Clinical characteristics of inpatients with coronavirus disease 2019 (COVID-19) in Sichuan province.四川省 2019 年冠状病毒病(COVID-19)住院患者的临床特征。
BMC Infect Dis. 2021 Feb 8;21(1):155. doi: 10.1186/s12879-021-05825-1.
2
Epidemiological and clinical characteristics of 1663 hospitalized patients infected with COVID-19 in Wuhan, China: a single-center experience.中国武汉 1663 例 COVID-19 住院患者的流行病学和临床特征:一项单中心经验。
J Infect Public Health. 2020 Sep;13(9):1202-1209. doi: 10.1016/j.jiph.2020.07.002. Epub 2020 Jul 17.
3
Clinical characteristics, laboratory abnormalities and CT findings of COVID-19 patients and risk factors of severe disease: a systematic review and meta-analysis.COVID-19 患者的临床特征、实验室异常和 CT 表现及重症危险因素的系统评价和荟萃分析。
Ann Palliat Med. 2021 Feb;10(2):1928-1949. doi: 10.21037/apm-20-1863. Epub 2021 Jan 27.
4
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
5
Clinical characteristics and drug therapies in patients with the common-type coronavirus disease 2019 in Hunan, China.中国湖南普通型 2019 冠状病毒病患者的临床特征和药物治疗方法。
Int J Clin Pharm. 2020 Jun;42(3):837-845. doi: 10.1007/s11096-020-01031-2. Epub 2020 May 14.
6
Clinical and epidemiological characteristics of pediatric SARS-CoV-2 infections in China: A multicenter case series.中国儿童 SARS-CoV-2 感染的临床和流行病学特征:一项多中心病例系列研究。
PLoS Med. 2020 Jun 16;17(6):e1003130. doi: 10.1371/journal.pmed.1003130. eCollection 2020 Jun.
7
Clinical characteristics and outcomes of 48 patients hospitalized for COVID-19 infection in Wuxi: A retrospective cohort study.无锡 48 例 COVID-19 感染住院患者的临床特征和结局:一项回顾性队列研究。
Medicine (Baltimore). 2021 Feb 5;100(5):e23991. doi: 10.1097/MD.0000000000023991.
8
Clinical characteristics of coronavirus disease 2019 in Gansu province, China.中国甘肃省2019冠状病毒病的临床特征
Ann Palliat Med. 2020 Jul;9(4):1404-1412. doi: 10.21037/apm-20-887. Epub 2020 Jul 13.
9
Factors Associated with a Positive Severe Acute Respiratory Syndrome Coronavirus 2 Testing in Suspected Cases Presenting with Pneumonia: A Retrospective Cohort Study in a Single Medical Center.与疑似肺炎患者 SARS-CoV-2 检测呈阳性相关的因素:单中心回顾性队列研究。
Respiration. 2020;99(9):739-747. doi: 10.1159/000508398. Epub 2020 Nov 18.
10
Epidemiological and clinical characteristics of 2019 novel coronavirus disease (COVID-19) in Jilin, China: A descriptive study.中国吉林2019新型冠状病毒病(COVID-19)的流行病学和临床特征:一项描述性研究。
Medicine (Baltimore). 2020 Nov 20;99(47):e23407. doi: 10.1097/MD.0000000000023407.

引用本文的文献

1
Epidemiology of asthma exacerbation in children before and after the COVID-19 pandemic: a retrospective study in Chengdu, China.COVID-19 大流行前后儿童哮喘恶化的流行病学:中国成都的一项回顾性研究。
BMC Pediatr. 2023 Nov 22;23(1):588. doi: 10.1186/s12887-023-04364-9.
2
Blood Transcriptomes of SARS-CoV-2-Infected Kidney Transplant Recipients Associated with Immune Insufficiency Proportionate to Severity.感染 SARS-CoV-2 的肾移植受者的血液转录组与免疫缺陷的严重程度成正比。
J Am Soc Nephrol. 2022 Nov;33(11):2108-2122. doi: 10.1681/ASN.2022010125. Epub 2022 Aug 30.
3
Heterogeneity and Risk of Bias in Studies Examining Risk Factors for Severe Illness and Death in COVID-19: A Systematic Review and Meta-Analysis.

本文引用的文献

1
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
2
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.中国2019年冠状病毒病(COVID-19)疫情的特征及重要经验教训:来自中国疾病预防控制中心72314例病例报告的总结
JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.
3
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.
研究2019冠状病毒病重症和死亡风险因素的研究中的异质性和偏倚风险:一项系统评价和荟萃分析
Pathogens. 2022 May 10;11(5):563. doi: 10.3390/pathogens11050563.
4
and SARS-CoV-2 Coinfections: A Review.以及新型冠状病毒2型合并感染:一篇综述。
Front Microbiol. 2022 Feb 3;12:747827. doi: 10.3389/fmicb.2021.747827. eCollection 2021.
5
Neurological Manifestations in a Cohort of Egyptian Patients with COVID-19: A Prospective, Multicenter, Observational Study.一组埃及新冠肺炎患者的神经学表现:一项前瞻性、多中心、观察性研究。
Brain Sci. 2022 Jan 1;12(1):74. doi: 10.3390/brainsci12010074.
6
Prevalence of comorbid tuberculosis amongst COVID-19 patients: A rapid review and meta-analysis.COVID-19患者中合并肺结核的患病率:快速回顾与荟萃分析
Int J Clin Pract. 2021 Nov;75(11):e14867. doi: 10.1111/ijcp.14867.
中国武汉 140 名 SARS-CoV-2 感染患者的临床特征。
Allergy. 2020 Jul;75(7):1730-1741. doi: 10.1111/all.14238. Epub 2020 Feb 27.
4
Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series.一组在中国武汉以外地区感染 2019 年新型冠状病毒(SARS-CoV-2)的患者的临床特征:回顾性病例系列。
BMJ. 2020 Feb 19;368:m606. doi: 10.1136/bmj.m606.
5
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
6
Epidemiologic and Clinical Characteristics of Novel Coronavirus Infections Involving 13 Patients Outside Wuhan, China.中国武汉以外地区 13 例新型冠状病毒感染的流行病学和临床特征。
JAMA. 2020 Mar 17;323(11):1092-1093. doi: 10.1001/jama.2020.1623.
7
A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version).新型冠状病毒(2019-nCoV)感染的肺炎快速诊治指南(标准版)。
Mil Med Res. 2020 Feb 6;7(1):4. doi: 10.1186/s40779-020-0233-6.
8
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.中国武汉 99 例 2019 年新型冠状病毒肺炎患者的流行病学和临床特征:描述性研究。
Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.
9
Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event.对新型冠状病毒(2019-nCoV)的全基因组进化分析否定了其是近期重组事件导致出现的假说。
Infect Genet Evol. 2020 Apr;79:104212. doi: 10.1016/j.meegid.2020.104212. Epub 2020 Jan 29.
10
Eosinopenia as a diagnostic marker of bloodstream infection in a general internal medicine setting: a cohort study.嗜酸性粒细胞减少作为普通内科环境下血流感染的诊断标志物:一项队列研究。
BMC Infect Dis. 2020 Jan 30;20(1):85. doi: 10.1186/s12879-020-4814-5.